Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: Similarities and differences

Current Cardiology Reviews

Volumn 6, Issue 3, 2010, Pages 138-149

  Soler, Ernest Palomeras ^a   Ruiz, Virgina Casado ^a  

^a HOSPITAL DE MATARÓ   (Spain)

Author keywords

References

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; LIPOPROTEIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTERY EMBOLISM; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CORONARY ARTERY EMBOLISM; DIABETES MELLITUS; DIET; DYSLIPIDEMIA; EPIDEMIOLOGICAL DATA; ETHNICITY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEREDITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERCOAGULOPATHY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IMMOBILIZATION; INCIDENCE; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MEDITERRANEAN DIET; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SMOKING; STROKE; THROMBOPHILIA;

EID: 77956520638     PISSN: 1573403X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340310791658785     Document Type: Article

References (153)

1. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ,Amarenco P. Autopsy prevalence of coronary atherosclerosis inpatients with fatal stroke. Stroke 2007; 38: 1203-10
2. Touzé E, Varenne O, Calvet D, Mas JL. Coronary riskstratification in patients with ischemic stroke or transient ischemicstroke attack. Int J Stroke 2007; 2: 177-83
3. Coca A, Messerli FH, Benetos A, et al. Predicting stroke risk inhypertensive patients with coronary artery disease: a report fromthe INVEST. Stroke 2008; 39: 343-8
4. De Silva DA, Woon FP, Moe KT, Chen CL, Chang HM, WongMC. Concomitant coronary artery disease among Asian ischaemicstroke patients. Ann Acad Med Singapore 2008; 37: 573-5
5. World statistics http://www.who.int/whosis/whostat/2008/es/index.html
6. Deaths according to the cause of death in Europe. www.ine.es
7. Deaths according to the cause of death, age and sex in Catalonia.www.idescat.cat
8. Evolution of mortality causes in Europe. http: //www.ine.es/jaxi/tabla.do?type=pcaxis&path=/t15/p417/e01/l0/&file=01001.px
9. Deaths according to the cause of death in Spain. http://www.ine.es/prensa/np545.pdf
10. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P, For the WHO MONICA (monitoringtrends and determinants in cardiovascular disease) Project.Contribution of trends in survival and coronary event rates tochanges in coronary heart disease mortality: 10-year results from37 WHO MONICA Project populations. Lancet 1999; 353: 1547-57
11. Goff DC, Nichaman MZ, Chan W, Ramsey DJ, Labarthe DR, Ortiz C. Greater incidence of hospitalized myocardial infarction amongMexican Americans than non-Hispanic whites. The Corpus ChristiHeart Project, 1988-1992. Circulation 1997; 95: 1433-40
12. Rosamond WD, Chambless LE, Folsom AR, et al. Trends in theincidence of myocardial infarction and in mortality due to coronaryheart disease. N Engl J Med 1998; 339: 861-7
13. Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades(1975 to 1995) long experience in the incidence, in-hospital andlong-term case-fatality rates of acute myocardial infarction: acommunity-wide perspective. J Am Coll Cardiol 1999; 33: 1533-9
14. McGovern PG, Jacobs DR Jr, Shahar E, et al. Trends in acutecoronary heart disease mortality, morbidity, and medical care from1985 through 1997: the Minnesota heart survey. Circulation 2001;104: 19-24
15. Roger VL, Jacobsen SJ, Weston SA, et al. Trends in the incidenceand survival of patients with hospitalized myocardial infarction,Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med 2002136: 341-348
16. Arciero TJ, Jacobsen SJ, Reeder GS, et al. Temporal trends in theincidence of coronary disease. Am J Med 2004; 117: 228-33
17. Roger VL. Epidemiology of myocardial infarction. Med ClinNorth Am 2007; 91: 537-52
18. Lorgis L, Zeller M, Beer JC, et al. Epidemiology of acute coronarysyndrome in Europe. Ann Cardiol Angeiol 2007; 56: S2-S7
19. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in thefrequency of onset of acute myocardial infarction. N Engl J Med 1985; 313: 1315-1322
20. Tofler G H, Muller J E, Stone PH, et al. Modifiers of timing andpossible triggers of acute myocardial infarction in theThrombolysis in Myocardial Infarction Phase II (TIMI II) StudyGroup. J Am Coll Cardiol 1992; 201049-201055
21. Goldberg RJ, Brady P, Muller JE, et al. Time of onset ofsymptoms of acute myocardial infarction. Am J Cardiol 1990; 66:140-4
22. Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342-4
23. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Strokeepidemiology: a review of population-based studies of incidence,prevalence, and case-fatality in the late 20th century. LancetNeurol 2003; 2: 43-53
24. Serena J, Dávalos, Segura T, Mostacero E, Castillo J. Stroke onawakening: looking for a more rational management. CerebrovascDis 2003; 16: 128-33
25. Elliott WJ. Circadian variation in the timing of stroke onset: ameta-analysis. Stroke 1998; 29: 992-6
26. Donnan G, Fisher M, MacLeod M, Davis MS. Stroke. Lancet 2008; 371: 1612-1623
27. Simons LA, Simons J, Friedlander Y, McCallum J. A comparisonof risk factors for coronary heart disease and ischaemic stroke: theDubbo Study of Australian Elderly. Heart Lung Circ 2009; 18:330-3
28. Coca A, Messerli FH, Benetos A, et al. Predicting stroke risk inhypertensive patients with coronary artery disease: a reports fromthe INVEST. Stroke 2008; 39: 343-8
29. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P. Autopsy prevalence of coronary atherosclerosis inpatients with fatal stroke. Stroke 2007; 38: 1203-10
30. Libby P. Current Concepts of the Pathogenesis of the AcuteCoronary Syndromes. Circulation 2001; 104: 365-72
31. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372: 570-84
32. Casscells W, Naghavi M, Willerson JT. Vulnerable atheroscleroticplaque: a multifocal disease. Circulation 2003; 107: 2072-5
33. Larsen AI, Galbraith PD, Ghali WA, Norris CM, Graham MM, Knudtson ML. APPROACH investigators. Characteristics andoutcomes of patients with acute myocardial infarction andangiographically normal coronary arteries. Am J Cardiol 2005; 95:261-3
34. Widimsky P, Stellova B, Groch L. Prevalence of normal coronaryangiography in the acute phase of suspected ST-elevationmyocardial infarction: experience from the PRAGUE studies. CanJ Cardiol 2006; 22: 1147-52
35. Ferrer-García MC, Hernández-Antolín RA, Pérez-Vizcaíno MJ, Conde-Vela C, Alfonso-Manterola F, Macaya-Miguel C. Myocardialinfarction with ST segment elevation and angiographycallynormal coronary arteries: epidemiology and mid-term follow-up. Med Clin 2007; 129: 694-6
36. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification ofsubtype of acute ischemic stroke. Definitions for use in amulticenter clinical trial. Stroke 1993; 24: 35-41
37. Moulin T, Tatu L, Crépin-Leblond T, Chavot D, Bergès S, Rumbach L. The Besançon Stroke Registry: An acute strokeregistry of 2.500 consecutive patients. Eur Neurol 1997; 38: 10-20
38. Martí-Vilalta JL, Arboix A. The Barcelona Stroke Registry. EurNeurol 1999; 41: 135-42
39. Vemmos KN, Takis CE, Georgilis K, et al. The Athens StrokeRegistry: Results of a five-year hospital-based study. CerebrovascDis 2000; 10: 133-41
40. Bang OY, Lee PH, Joo SY, Lee JS, Joo IS, Huh K. Frequency andmechanisms of stroke recurrences after cryptogenic stroke. AnnNeurol 2003; 54: 227-34
41. Arboix A, Cendrós V, Besa M, et al. Trends in risk factors, strokesubtypes and outcome. Nineteen-year data from the Sagrat CorHospital of Barcelona Stroke Registry. Cerebrovasc Dis 2008; 26:509-16
42. Palomeras E, Fossas P, Cano A, Sanz P. Cryptogenic infarcts. A 1-year follow-up study. Neurología 2009; 24: 304-8
43. Wolf PA, D'Agostino RB, O'Neal MA, et al. Secular trends instroke incidence and mortality. The Framingham Study. Stroke 1992; 23: 1551-5
44. Rosamond W, Flegal K, Furie K, et al. Heart disease and strokestatistics-2008 update: a report from the American Heart AssociationStatistics Committee and Stroke statistics Subcommittee. Circulation 2008; 117(4): e25-146
45. Romero JR, Morris J, Pikula A. Stroke prevention: modifying riskfactors. Ther Adv Cardiovasc Dis 2008; 2(4): 287-303
46. Marín A, Medrano MJ, González J, et al. Risk of ischemic heartdisease and acute myocardial infarction in a Spanish population:observational prospective study in a primary-care setting. BMCPublic Health 2006; 6: 38
47. Appelros P, Stegmayr B, Terént A. Sex differences in strokeepidemiology. A systematic review. Stroke 2009; 40: 1082-90
48. Reeves MJ, Bushnell CD, Howard G, et al. Sex differences instroke: epidemiology, clinical presentation, medical care, andoutcomes. Lancet Neurol 2008; 7: 915-26
49. Förster A, Gass A, Kern R, et al. Gender differences in acuteischemic stroke: etiology, stroke patterns and response tothrombolysis. Stroke. 2009; 40: 2428-32
50. Roquer J, Rodriguez A, Gomis M. Sex differences in first-everacute stroke. Stroke 2003; 34: 1581-5
51. Turtzo C, McCullough LD. Sex Differences in Stroke. CerebrovascDis 2008; 26(5): 462-74
52. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of thecharacteristics, treatments and outcomes of patients with acutecoronary syndromes in Europe in the Mediterranean basin. TheEuro Heart Survey of Acute Coronary Syndromes (Euro HeartSurvey ACS). Eur Heart J 2002; 23: 1190-201
53. Bradshaw PJ, Ko DT, Newman AM, Donovan LR, Tu JV. Validityof the GRACE (Global Registry of Acute Coronary Events) acutecoronary syndrome prediction model for six month post-dischargedeath in an independent data set. Heart 2006; 92: 905-9
54. Heras M, Bueno H, Bardají A, et al. Magnitude and consequencesof undertreatment of high-risk patients with non-ST segmentelevation acute coronary syndromes: insights from theDESCARTES Registry. Heart 2006; 92: 1571-6
55. Bello N, Mosca L. Epidemiology of coronary heart disease inwomen. Prog Cardiovasc Dis 2004; 46: 287-95
56. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence amongblack, White and Hispanic residents of an urban community. Am JEpidemiol 1998; 147: 259-68
57. Tsaras G, Owusu-Ansah A, Boateng FO, Amoateng-Adjepong Y. Complications associated with sickle cell trait: a brief narrativereview. Am J Med 2009; 122: 507-12
58. Vivo RP, Krim SR, Cevik C, Witteles RM. Heart failure inHispanics. J Am Coll Cardiol 2009; 53: 1167-75
59. Dodani S. Excess coronary artery disease risk in South Asianimmigrants: can dysfunctional high-density lipoprotein explainincreased risk? Vasc Health Risk Manag 2008; 4: 953-61
60. Rexrode KM, Ridker PM, Hegener HH, Buring JE, Manson JE, Zee RY. Genetic variation of the androgen receptor and risk ofmyocardial infarction and ischemic stroke in women. Stroke 2008;39: 1590-2
61. Schürks M, Kurth T, Ridker PM, Buring JE, Zee RY. Associationbetween polymorphisms in the beta2-adrenergic receptor gene withmyocardial infarction and ischaemic stroke in women. ThrombHaemost 2009; 101: 351-8
62. Gouldbourt U, Tanne D. Body height is associated with decreasedlong term stroke but not coronary heart disease mortality? Stroke 2002; 33: 743-8
63. Tanne D, Medalie JH, Gouldbourt U. Body fat distribution andlong term risk of stroke mortality. Stroke 2005; 36: 1021-5
64. Myint PK, Vowler SL, Woodhouse PR, Redmayne O, Fulcher RA. Winter excess in hospital admissions, in-patient mortality andlength of acute hospital stay in stroke: a hospital database studyover six seasonal years in Norfolk, UK. Neuroepidemiology 2007;28: 79-85
65. Houck PD, Lethen JE, Riggs MW, Gantt DS, Dehmer GJ. Relationof atmospheric pressure changes and the occurrences of acutemyocardial infarction and stroke. Am J Cardiol 2005; 96: 45-51
66. White HD, Chew DP. Acute myocardial infarction. Lancet 2008;372: 570-84
67. Carrera E, Maeder-Ingvar M, Rossetti AO, Devuyst G, Bogousslavsky J. Lausanne Stroke Registry. Trends in risk factors,patterns and causes in hospitalized strokes over 25 years: TheLausanne Stroke Registry. Cerebrovasc Dis 2007; 24: 97-103
68. Vasan R, Larson MG, Leip EP, Kannel WB, Levy D. Assessmentof frequency to progression to hypertension in non-hypertensiveparticipants in the Framingham Heart Study: a cohort study. Lancet 2001; 358: 1682-6
69. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usualblood pressure to vascular mortality: a meta-analysis of individualdata for one million adults in 61 prospective studies. Lancet 2002;360: 1903-13
70. Kannel Wb, Wolf PA, Verter J, mcMara P. FraminghamStudyinsights on the hazards of elevated blood pressure. JAMA 2008; 300: 2545-7
71. Heart Outcomes Prevention Evaluation Study Investigators. Effectsof an angiotensin-converting-enzyme inhibitor, ramipril, oncardiovascular events in high-risk patients. N Engl J Med 2000;342: 145-53
72. PROGRESS Collaborative group. Randomised trial of aperindopril-based blood-pressure-lowering regimen among 6105individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41
73. Strazzullo P, D'Elia L, Kandala N, Capuccio FP. Salt intake, strokeand cardiovascular disease: a meta-analysis of prospective studies. BMJ 2009; 339: b4567
74. Cooper R, Cutler J, Desvigne-Nickens P, et al. Trends anddisparities in coronary heart disease, stroke and other cardiovasculardiseases in the United States. Findings of the NationalConferences on Cardiovascular Disease Prevention. Circulation 2000; 102: 3137-47
75. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type2 diabetes mellitus: insights from mechanistics studies. Lancet 2008; 371: 1800-9
76. Morrish NJ, Wang SL, Stevens LK. Mortality and causes of deathin the WHO Multinational Study of Vacular Disease in Diebates.Diabetologia 2001; 44(suppl2): S14-21
77. Moss SE, Klein R, Klein BE. Cause-specific mortality in apopulation-based study of diabetes. Am J Public Health 1991;1158-62
78. Rodriguez BL, Lau N, Burchfiel CM, et al. Glucose intoleranceand 23-year risk of coronary heart disease and total mortality. TheHonolulu Heart Program. Diabetes Care 1999; 22: 1262-5
79. Burchfiel CM, Curb JD, Rodriguez BL. Glucose intolerante and22-year stroke incidente. The Honolulu Heart Program. Stroke 1994; 25: 951-7
80. Vermeer SE, Sandee W, Algra A. Impaired glucose toleranceincreases stroke risk in nondiabetic patients with transient ischemicattack or minor ischemic stroke. Stroke 2006; 37: 1413-8
81. Bogousslavsky J, Van Melle G, Regli F. The Lausanne StrokeRegistry: analysis of 1.000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92
82. Hanson GK. Inflammation, atherosclerosis and coronary arterydisease. N Engl J Med 2005; 352: 1685-95
83. Verschuren WM, Jacobs DR, Bloemberg BP, et al. Serum totalcholesterol and long-term coronary heart disease mortality indifferent cultures. Twenty-five-year follow-up of the sevencountries study. JAMA 1995; 274: 131-6
84. Austin MA, McKnight B, Edwards KL, et al. Cardiovasculardisease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study. Circulation 2000; 101: 2777-82
85. Miller M, Seidler A, Kwiterovich PO, Pearson TA. Long-termpredictors of subsequent cardiovascular events with coronaryartery disease and "desirable" levels of plasma total cholesterol. Circulation 1992; 86: 1165-70
86. Zhang X, Patel A, Horibe H, et al. Cholesterol, coronary heartdisease and stroke in the Asian Pacific region. Int J Epidemiol 2003; 32: 563-72
87. Bots ML, Elwood PC, Nikitin Y, et al. Total and HDL cholesteroland risk of stroke. EUROSTROKE: a collaborative study amongresearch in Europe. J Epidemiol Commun Health 2002;56(suppl1): 19-24
88. Shahar E, Chambless LE, Rosamond W, et al. Plasma lipid profileand incident ischemic stroke: the Atherosclerosis Risk inCommunities (ARIC) study. Stroke 2003; 34: 623-31
89. Ansell BJ. Cholesterol, stroke risk and stroke prevention. CurrAtheroscler Rep 2000; 2: 92-6
90. Renaud S, Blache D, Dumont E, Thevenon C, Wissendanger T. Platelet function after cigarette smoking in relation to nicotine andcarbon monoxide. Clin Pharmacol Ther 1984; 36: 389-95
91. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS. Effects of tobacco and non-tobacco cigarette smoking onendothelium and platelets. Clin Pharmacol Ther 1985; 37: 529-33
92. Lassila R, Seyberth HW, Haapanen A, Schweer H, Koskenvuo M, Laustiola KE. Vasoactive and atherogenic effects of cigarettesmoking: a study of monozygotic twins discordant for smoking. BMJ 1988; 297: 955-7
93. Kool MJ, Hoeks AP, Struijker Boudier HA, Reneman RS, VanBortel LM. Short- and long-term effects of smoking on arterialwall properties in habitual smokers. J Am Coll Cardiol 1993; 22:1881-6
94. Schwarcz TH, Hogan LA, Endean ED, Roitman IT, Kazmers A,Hyde GL. Thromboembolic complications of polycythemia:polycythemia vera versus smokers' polycythemia. J VascSurg 1993; 17: 518-22
95. Willett WC, Green A, Stampfer MJ, et al. Relative and absoluteexcess risks of coronary heart disease among women who smokecigarettes. N Engl J Med 1987; 317: 1303-9
96. Nyboe J, Jensen G, Appleyard M, Schnohr P. Smoking and the riskof first acute infarction. Am Heart J 1991; 122: 438-47
97. Sauer WH, Berlin JA, Strom BL, Miles C, Carson JL, Kimmel SE. Cigarette yield and the risk of myocardial infarction in smokers. Arch Intern Med 2002; 162: 300-6
98. Castelli WP. Cardiovascular disease: Pathogenesis, epidemiology,and risk among users of oral contraceptives who smoke. Am JObstet Gynecol 1999; 180: S349-56
99. LaCroix AZ, Lang J, Scherr P, et al. Smoking and mortality amongolder men and women in three communities. N Engl J Med 1991;324: 1619-25
100. Shinton R, Beevers G. Meta-analysis of relation between cigarettesmoking and stroke. BMJ 1989; 298: 789-794
101. Whisnant JP, Wiebers DO, O'Fallon WM, Sicks JD, Frye RL. Apopulation-based model of risk factors for ischemic stroke:Rochester,Minnesota. Neurology 1996; 47: 1420-8
102. Bonita R, Duncan J, Truelsen T, Jackson RT, Beaglehole R. Passive smoking as well as active smoking increases the risk ofacute stroke. Tob Control 1999; 8: 156-60
103. You RX, Thrift AG, McNeil JJ, Davis SM, Donnan GA. Ischemicstroke risk and passive exposure to spouses' cigarette smoking.Melbourne Stroke Risk Factor Study (MERFS) Group. Am JPublic Health 1999; 89: 572-5
104. Suh I, Shaten BJ, Cutler JA, Kuller LH. Alcohol use and mortalityfrom coronary heart disease: the role of high density lipoproteincholesterol. Ann Intern Med 1992; 116: 881-7
105. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the Frenchparadox for coronary heart disease. Lancet 1992; 339: 1523-6
106. Register TC, Cline JM, Shively CA. Health issues in postmenopausalwomen who drink. Alcohol Res Health 2002; 26: 299-307
107. Skog OJ. Public health consequences of the J-curve hypothesis ofalcohol problems. Addiction 1996; 91: 325-37
108. McElduff P, Dobson AJ. How much alcohol and how often?Population based case-control study of alcohol consumption andrisk of a major coronary event. BMJ 1997; 314: 1159-64
109. Flesch M, Rosenkranz S, Erdmann E, Bohm M. Alcohol and therisk of myocardial infarction. Basic Res Cardiol 2001; 96: 128-35
110. Murray RP, Connett JE, Tyas SL. Alcohol volume, drinkingpattern, and cardiovascular disease morbidity and mortality: isthere a U-shaped function? Am J Epidemiol 2002; 155: 242-8
111. Tolstrup J, Jensen MK, Tjonneland A, Overvard K, Mukamal KJ, Gronbaek M. Prospective study of alcohol drink patterns andcoronary heart disease in women and men. BMJ 2006; 332: 1244-8
112. Malyutina S, Bobak M, Kurilovitch S, et al. Relation betweenheavy and binge drinking and all-cause and cardiovascularmortality in Novosibirsk,Russia: a prospective cohort study. Lancet 2002; 360: 1448-54
113. Reynolds K, Lewis LB, Nolen JDL, Kinney GL, Sathya B, He J.Alcohol consumption and risk of stroke: a meta-analysis. J AmMed Assoc 2003; 289: 579-88
114. Elkind MSV, Sciacca R, Boden-Albala B, Rundek T, Paik MC, Sacco RL. Moderate alcohol consumption reduces risk of ischemicstroke: The Northern Manhattan Study. Stroke 2006; 37: 13-9
115. Mazzaglia G, Britton AR, Altmann DR, Chenet L. Exploring therelationship between alcohol consumption and non-fatal or fatalstroke: a systematic review. Addiction 2001; 96: 1743-56
116. Hillbom M, Numminen H, Juvela S. Recent heavy drinking ofalcohol and embolic stroke. Stroke 1999; 30: 2307-12
117. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. Therelation of overweight to cardiovascular risk factors amongchildren and adolescents: the Bogalusa Heart Study. Pediatrics.1999; 103: 1175-82
118. Haslam DW, James WPT. Obesity. Lancet 2005; 366: 1197-209
119. Gu DP, Zhang W, Bansback N, Amarsi Z, Birmingham L, Anis AH. The incidence of co-morbidities related to obesity andoverweight: a systematic review and meta-analysis. BMC PublicHealth 2009; 9: 88
120. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, hGoldman L. Adolescent overweight and future adult coronary heartdisease. N Engl J Med 2007; 357: 2371-9
121. Wood PD, Stefanick ML, Dreon DM, et al. Changes in plasmalipids and lipoproteins in overweight men during weight lossthrough dieting as compared with exercise. N Engl J Med 1988;319: 1173-9
122. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise oncoronary endothelial function in patients with coronary arterydisease. N Engl J Med 2000; 342: 454-60
123. Sherman DL. Exercise and endothelial function. Coron Artery Dis 2000; 11: 117-22
124. Lee CD, Folsom AR, Blair SN. Physical activity and stroke risk. AMeta-Analysis. Stroke 2003; 34: 2475-82
125. Berlin JA, Colditz GA. A meta-analysis of physical activity in theprevention of coronary heart disease. Am J Epidemiol 1990; 132:612-28
126. Manson J, Greenland P, LaCroix A, et al. Walking compared withvigorous exercise for the prevention of cardiovascular events inwomen. N Engl J Med 2002; 347: 716-25
127. Hambrecht R, Walther C, Möbius-Winkler S, et al. Percutaneouscoronary angioplasty compared with exercise training in patientswith stable coronary artery disease: a randomized trial. Circulation 2004; 109: 1371-8
128. Sacco RL, Gan R, Boden-Albala B, et al. Leisure-time physicalactivity and ischemic stroke risk. The Northern Manhattan StrokeStudy. Stroke 1998; 29: 380-7
129. Willett WC, Sacks F, Trichopoulou A, et al. Mediterranean dietpyramid: a cultural modelfor healthy eating. Am J Clin Nutr 1995; 61: 1402s-1406s
130. De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate ofcardiovascular complications after myocardial infarction: finalreport of the Lyon Diet Heart Study. Circulation 1999; 99: 779-85
131. Knoops KT, de Groot LC, Kromhout D, et al. Mediterranean diet,lifestyle factors, and 10-year mortality in elderly European menand women: the HALE project. JAMA 2004; 292: 1433-9
132. Fung TT, Rexrode KM, Mantzoros CS, et al. Mediterranean dietand incidence of and mortality from coronary heart disease andstroke in women. Circulation 2009; 119; 1093-100
133. Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetableintake in relation to risk of ischemic stroke. JAMA 1999; 282:1233-9
134. González Babarro E, Román Rego A, González-Juanatey JR. Cardioembolic stroke: call for a multidisciplinary approach. Cerebrovasc Dis 2009; 27(suppl1): 82-7
135. Stroke Risk in Atrial Fibrillation Working Group. Independentpredictors of stroke in patients with atrial fibrillation. Neurology 2007; 69: 546-54
136. Stroke Risk in Atrial Fibrillation Working Group. Comparison of12 risk stratification schemes to predict stroke in patients withnonvalvular atrial fibrillation. Stroke 2008; 39: 1901-10
137. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Tacker SB. Homocyst(e)ine and cardiovascular disease: A systematicreview of the evidence with special emphasis on case-controlstudies and nested case-control studies. Int J Epidemiol 2002; 31:59-70
138. Kaplan ED. Association between homocyst(e)ine levels and risk ofvascular events. Drugs Today (Barc) 2003; 39: 175-92
139. Hankey GJ, Eikelboom JW, van Bockxmeer F, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic strokeand its pathogenic subtypes. Stroke 2001; 32: 1793-9
140. Brey RL, Stallworth CL, McGlasson DL, et al. Antiphospholipidantibodies and stroke in young women. Stroke 2002; 33: 2396-400
141. Schwartz D. Utility of routine coagulation studies in emergencydepartment patients with suspected acute coronary syndromes. IsrMed Assoc J 2005; 7: 502-6
142. Nachman RL. Lipoprotein (a): molecular mischief in themicrovasculature. Circulation 1997; 96: 2485-7
143. Morrisett JD. The role of lipoprotein (a) in atherosclerosis. CurrAtheroscler Rep 2000; 2: 243-50
144. Ohira T, Schreiner PJ, Morrisett JD, Chambless LE, Rosamond WD, Folsom AR. Lipoprotein(a) and incident ischemic stroke: theAtherosclerosis Risk in Communities (ARIC) study. Stroke 2006;37: 1407-12
145. McQueen MJ, Hawken SW, Wang X, et al. Lipids, lipoproteins,and apolipoproteins as risk markers of myocardial infarction in 52countries (the INTERHEART study): a case-control study. Lancet 2008; 372: 224-33
146. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-Reactive Protein and low-density lipoprotein cholesterol levelsin the prediction of first cardiovascular events. N Engl J Med 2002;347: 1557-65
147. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive proteinand other markers of inflammation in the prediction ofcardiovascular disease in women. N Engl J Med 2000; 342: 836-43
148. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of CReactiveProtein and risk of ischemic stroke and transient ischemicattack. Stroke 2001; 32: 2575-9
149. Pradhan AD, Manson JE, Rossouw JE, et al. Inflammatorybiomarkers, hormone replacement therapy, and incident coronaryheart disease: prospective analysis from the Women's HealthInitiative observational study. JAMA 2002; 288: 980-7
150. Curb JD, Abbott RD, Rodriguez BL, et al. C-reactive protein andthe future risk of thromboembolic stroke in healthy men. Circulation 2003; 107: 2016-20
151. Li C, Engström G, Hedblad B. Leukocyte count is associated withincidence of coronary events, but not with stroke: a prospectivecohort study. Atherosclerosis 2010; 209(2): 545-50
152. Cardona Portela P, Campdelacreu Fumadó J, Quesada García H, Rubio Borrego F. Sleep-disordered breathing and acute stroke.Cerebrovasc Dis 2009; 27: 104-10
153. Kiely JL, McNicholas WT. Cardiovascular risk factors in patientswith obstructive sleep apnoea syndrome. Eur Respir J 2000; 16:128-33.